150 related articles for article (PubMed ID: 31537095)
1. [Correlations between secondary hypogammaglobulinaemia, infections and mortality and the need for preventive immunoglobulin replacement in patients with chronic lymphoid leukaemia].
Losonczy H; Nagy Á; Kosztolányi S; Tóth O; Csalódi R; Hussain A; Szomor Á
Orv Hetil; 2019 Sep; 160(38):1487-1494. PubMed ID: 31537095
[TBL] [Abstract][Full Text] [Related]
2. Treatment of hypogammaglobulinaemia in chronic lymphocytic leukaemia by low-dose intravenous gammaglobulin.
Jurlander J; Geisler CH; Hansen MM
Eur J Haematol; 1994 Aug; 53(2):114-8. PubMed ID: 8088382
[TBL] [Abstract][Full Text] [Related]
3. Intravenous immune globulin in chronic lymphocytic leukaemia.
Gamm H; Huber C; Chapel H; Lee M; Ries F; Dicato MA
Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):17-20. PubMed ID: 8033428
[TBL] [Abstract][Full Text] [Related]
4. Randomized trial of intravenous immunoglobulin prophylaxis for patients with chronic lymphocytic leukaemia and secondary hypogammaglobulinaemia.
Boughton BJ; Jackson N; Lim S; Smith N
Clin Lab Haematol; 1995 Mar; 17(1):75-80. PubMed ID: 7621634
[TBL] [Abstract][Full Text] [Related]
5. Serial Serum Immunoglobulin G (IgG) Trough Levels in Patients with X-linked Agammaglobulinemia on Replacement Therapy with Intravenous Immunoglobulin: Its Correlation with Infections in Indian Children.
Suri D; Bhattad S; Sharma A; Gupta A; Rawat A; Sehgal S; Singh S; Gupta S
J Clin Immunol; 2017 Apr; 37(3):311-318. PubMed ID: 28321612
[TBL] [Abstract][Full Text] [Related]
6. Immunoglobulin replacement therapy in chronic lymphocytic leukaemia patients with hypogammaglobulinaemia and infection.
Keegan A; Dennington PM; Dhondy N; Mulligan SP
Eur J Haematol; 2022 Jun; 108(6):460-468. PubMed ID: 35152500
[TBL] [Abstract][Full Text] [Related]
7. Managing hypogammaglobulinaemia secondary to haematological malignancies in Australia and New Zealand: a clinician survey.
Wong J; Wood EM; Crispin P; Weinkove R; McQuilten ZK;
Intern Med J; 2019 Mar; 49(3):358-363. PubMed ID: 30129248
[TBL] [Abstract][Full Text] [Related]
8. [Prognostic value of absolute monocyte count in chronic lymphocytic leukaemia].
Szerafin L; Jakó J; Riskó F
Orv Hetil; 2015 Apr; 156(15):592-7. PubMed ID: 25845318
[TBL] [Abstract][Full Text] [Related]
9. High- vs low-dose immunoglobulin therapy in the long-term treatment of X-linked agammaglobulinemia.
Liese JG; Wintergerst U; Tympner KD; Belohradsky BH
Am J Dis Child; 1992 Mar; 146(3):335-9. PubMed ID: 1543181
[TBL] [Abstract][Full Text] [Related]
10. Clinical and laboratory correlates of lung disease and cancer in adults with idiopathic hypogammaglobulinaemia.
Brent J; Guzman D; Bangs C; Grimbacher B; Fayolle C; Huissoon A; Bethune C; Thomas M; Patel S; Jolles S; Alachkar H; Kumaratne D; Baxendale H; Edgar JD; Helbert M; Hambleton S; Arkwright PD
Clin Exp Immunol; 2016 Apr; 184(1):73-82. PubMed ID: 26646609
[TBL] [Abstract][Full Text] [Related]
11. Intravenous immunoglobulin replacement prevents severe and lower respiratory tract infections, but not upper respiratory tract and non-respiratory infections in common variable immune deficiency.
Favre O; Leimgruber A; Nicole A; Spertini F
Allergy; 2005 Mar; 60(3):385-90. PubMed ID: 15679727
[TBL] [Abstract][Full Text] [Related]
12. Antibody deficiency secondary to chronic lymphocytic leukemia: Should patients be treated with prophylactic replacement immunoglobulin?
Dhalla F; Lucas M; Schuh A; Bhole M; Jain R; Patel SY; Misbah S; Chapel H
J Clin Immunol; 2014 Apr; 34(3):277-82. PubMed ID: 24557494
[TBL] [Abstract][Full Text] [Related]
13. [Chronic lymphoid leukemia and intravenous immunoglobulins].
Feugier P; Tomowiak C; Daguindau N; Perrot A
Rev Med Interne; 2007 Jun; 28 Spec No 2():2-4. PubMed ID: 17893959
[No Abstract] [Full Text] [Related]
14. Early intravenous immunoglobulin replacement in hypogammaglobulinemic heart transplant recipients: results of a clinical trial.
Sarmiento E; Diez P; Arraya M; Jaramillo M; Calahorra L; Fernandez-Yañez J; Palomo J; Sousa I; Hortal J; Barrio J; Alonso R; Muñoz P; Navarro J; Vicario J; Fernandez-Cruz E; Carbone J
Transpl Infect Dis; 2016 Dec; 18(6):832-843. PubMed ID: 27639067
[TBL] [Abstract][Full Text] [Related]
15. The clinical significance of hypogammaglobulinaemia and serum immunoglobulin G subclass deficiency in patients with chronic lymphocytic leukaemia (CLL).
Best OG; Crassini K; Freeman JA; Mulligan SP;
Scand J Infect Dis; 2013 Sep; 45(9):729. PubMed ID: 23826794
[No Abstract] [Full Text] [Related]
16. Hypogammaglobulinaemia in low grade B cell tumours; significance and therapy.
Chapel H; Griffiths H; Brennan V; Bunch C; Lea J; Lee M
Immunol Invest; 1991 Apr; 20(2):187-91. PubMed ID: 1864637
[TBL] [Abstract][Full Text] [Related]
17. Case 22-2005: intravenous immune globulin in chronic lymphocytic leukemia.
Newcom SR
N Engl J Med; 2005 Oct; 353(17):1862-3; author reply 1862-3. PubMed ID: 16251548
[No Abstract] [Full Text] [Related]
18. Subcutaneous immunoglobulin in lymphoproliferative disorders and rituximab-related secondary hypogammaglobulinemia: a single-center experience in 61 patients.
Compagno N; Cinetto F; Semenzato G; Agostini C
Haematologica; 2014 Jun; 99(6):1101-6. PubMed ID: 24682509
[TBL] [Abstract][Full Text] [Related]
19. [Secondary deficiencies of humoral immunity in hematology: what management?].
Feugier P; Tomowiak C; Daguindau N; Perrot A
Rev Med Interne; 2007 Jun; 28 Spec No 2():1. PubMed ID: 17893958
[No Abstract] [Full Text] [Related]
20. Immunoglobulin replacement in patients with chronic lymphocytic leukemia (CLL): kinetics of immunoglobulin metabolism.
Chapel HM; Lee M
J Clin Immunol; 1992 Jan; 12(1):17-20. PubMed ID: 1551938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
